CENTAUR MEDIA PLC Logo

CENTAUR MEDIA PLC

Provides business intelligence, learning, and consultancy for marketing & legal professionals.

CAU | IL

Overview

Corporate Details

ISIN(s):
GB0034291418
LEI:
2138005WK87G7DQRQI62
Country:
United Kingdom
Address:
10 YORK ROAD, SE1 7ND LONDON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Centaur Media PLC is an international provider of business intelligence, learning, and specialist consultancy services. The company focuses on the marketing and legal industries, operating through a portfolio of leading brands. Its two primary segments are Xeim, which serves the marketing and communications sector, and The Lawyer, a key resource for the legal profession. Centaur delivers strategically important services and develops proprietary datasets, aiming to provide its customers with essential information and a competitive advantage, enabling professionals and businesses to excel.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 09:28
Share Issue/Capital Change
Update on Return of Capital
English 10.0 KB
2025-10-22 13:03
Major Shareholding Notification
Holding(s) in Company
English 53.3 KB
2025-10-21 17:39
Major Shareholding Notification
Holding(s) in Company
English 23.4 KB
2025-10-21 15:12
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-10-13 08:00
Remuneration Information
Director/PDMR Shareholding
English 25.2 KB
2025-10-08 15:00
M&A Activity
Sale of The Lawyer
English 11.0 KB
2025-09-17 08:00
Interim Report
Interim results for the 6 months ended 30 Jun 2025
English 867.2 KB
2025-09-05 15:00
Major Shareholding Notification
Holding(s) in Company
English 53.2 KB
2025-08-27 13:30
Major Shareholding Notification
Holding(s) in Company
English 53.1 KB
2025-08-19 10:39
Major Shareholding Notification
Holding(s) in Company
English 52.8 KB
2025-07-18 12:30
M&A Activity
Sale of MiniMBA and Notice of Results
English 12.0 KB
2025-06-25 08:00
M&A Activity
Conditional agreement for the sale of MiniMBA
English 82.0 KB
2025-05-09 09:16
M&A Activity
Response to Media Speculation
English 7.6 KB
2025-05-08 16:23
Post-Annual General Meeting Information
Signed Resolutions from Annual General Meeting
English 2.4 MB
2025-04-03 16:11
Remuneration Information
Revised Centaur Media LTIP Rules
English 487.8 KB

Automate Your Workflow. Get a real-time feed of all CENTAUR MEDIA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CENTAUR MEDIA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CENTAUR MEDIA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.